NOV 17, 2015 08:00 AM PST

Unleashing the power of biobanks to drive translational science forward

SPONSORED BY: PerkinElmer, Inc., PerkinElmer, Inc.
  • Biorefinery Scientist, Integrated Biobank of Luxembourg
      Dr. Mathay's research background is molecular cell biology with a specialization in dermatology. She holds a PhD in Biomedical and Pharmaceutical Sciences from the University of Namur (Belgium).
      Her background includes "Specialized Studies in Applied Biological Sciences (DES)" including traineeships at the Karolinska Institutet in Stockholm and the Agricultural University of Gembloux (GxABT). She worked previously in transdisciplinary applied medical research projects from the Région Wallonne.
      In 2010, Dr. Mathay joined the Integrated Biobank of Luxembourg as Biorefinery Scientist. In IBBL she is organizing and supervising activities of the Biorefinery and Biospecimen Research laboratory and is deeply involved in Lab Automation, Quality Control and Validation of Analytical Laboratory Methods. Important publications include fundamental dermatology research publications and method validation papers.
      Dr. Mathay will discuss automation of nucleic acid extraction of two Biobanking workflows. The JANUS® chemagic automated workstation is a robust and quick magnetic beads-based nucleic acid extraction method which permits to process different sample types and volumes. The DNA extraction workflows were formally validated the DNA extraction workflows from human blood and stool and this presentation will illustrate the advantages of automated sample handling and extraction of DNA from blood and stool samples and their related formal method validation.
    • Chief Operating Officer, RUCDR Infinite Biologics, Rutgers University
        RUCDR Infinite Biologics is the world's largest academic based biorepository managing precious biological resources for NIH, foundations and industrial clients. Andrew Brooks is an Associate Professor at UMDNJ/Rutgers and a molecular neuroscientist whose research focuses on deciphering the molecular mechanisms that underlie memory and learning. Dr. Brooks is a well-recognized genomicist and has been involved in the development and implementation of cutting edge molecular based technologies for nucleic acid and protein analyses.
        Dr. Brooks will present effective approaches to high throughput quality control of extracted nucleic acids using the PerkinElmer LabChip® DS microvolume spectroanalysis . A variety of techniques were compared and data will be presented to show how the LabChip DS provides rapid accurate quantification of nucleic acids (and contaminants) with the ease and simplicity of spectroscopic techniques and the specificity of fluorescent quantification assays.
      • Director of Strategic Marketing, PerkinElmer Informatics
          Jens Hoefkens oversees the non-clinical life science informatics portfolio at PerkinElmer. His responsibilities cover the TIBCO® Spotfire franchise, the Enterprise R&D collaboration platforms, and the Signals data management platform. Jens has over a decade of experience in running successful bioinformatics businesses with a special emphasis on drug discovery, translational research, and cross-OMICS data integration Prior to joining PerkinElmer, Jens was the Head of the Expressionist business unit at Genedata, where he managed all aspects of the business, including sales, marketing, services, and software development. In that role Jens successfully expanded the Expressionist product line to include support for Next Generation Sequencing and Mass Spectrometry data. Jens holds a dual major PhD in Mathematics and Physics from Michigan State University.
          In this webinar, Dr. Hoefkens will present PerkinElmer Signals® a cloud-based data management platform that has been designed with flexible and scalable data models to provide the scalability and agility required to support modern life science research. To illustrate the versatility of the platform, we look at examples in areas as varied as Translational Medicine and High Content Screening.

        DATE: November 17th, 2015
        TIME: 8am PDT, 11am EDT, 4pm GMT

        Biobanks provide important capacity to collect large genomic data sets intended to enable the study of genetic signatures of an identified population. An essential step in genetic research is the isolation of high quality DNA or RNA. Many downstream biobanking applications are adversely affected by untreated or poor quality sample. Large amounts of cellular or other contaminating materials in complex mixtures often hinder many of the subsequent reactions and techniques. Thus, a method for the efficient, reliable and reproducible isolation of nucleic acids from complex biological mixtures is essential. This webinar presents innovative nucleic acid extraction technologies that help ensure high purity, high yield DNA/RNA. Speakers will also offer techniques for remote analysis and comparison of resulting data by multiple research groups in a biobanking workflow.

        Show Resources
        Loading Comments...